Post

APAC led in trials for 2023, with the majority in Phase II

According to leading data and analytics company GlobalData’s Clinical Trials Database, among the clinical trials for 2023, Phase II led …

FDA lifts two-year clinical hold on CytoDyn’s HIV trial

The FDA has lifted the clinical hold on CytoDyn’s leronlimab, allowing the company to evaluate the therapy as a treatment …

Artiva prepares to kick off Phase I/II trial for NK cell therapy

Artiva Therapeutics is looking to dose the first patient in a Phase I/II trial assessing its cell therapy AlloNK in …

Unlearn introduces new tool for clinical trial planning

Unlearn has unveiled a web-based application aimed at revolutionising the efficiency of clinical trial planning. TrialPioneer is now available for free …

Bristol Myers Squibb reports data from Phase III multiple sclerosis trial

Bristol Myers Squibb (BMS) has unveiled the latest data from the Phase III DAYBREAK clinical trial, highlighting the long-term efficacy …